
-
2008
Company Description
EnzymeRx is a biotechnology company developing uricase-PEG 20 for the treatment of resistant and refractory gout and related indications.
EnzymeRx! a private, clinical stage biotechnology company developing uricase-PEG 20 for the treatment of resistant and refractory gout and related indications in which hyperuricemia plays a causative role. Our patented formulation of pegylated uricase is designed to have a long half life as well as reduced immunogenicity.
-
Manufacturer:
Science and Engineering -
Formed:
2008 -
Company Website:
-
Company E-mail:
-
Company Address:
17 Arcadian Avenue, Suite 104Paramus, NJUnited States -
CEO:
- Tony Fiorino
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits